Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Day

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Annals of the Royal College of Surgeons of England|April 1, 2010
Comment on: Clarity of languageChris Day
Clinical Liver Disease|April 18, 2019
Natural history and factors influencing the course of alcohol-related liver diseaseStuart Kendrick, Chris Day
Imprint|March 5, 2004
Nurses strengthen the fabric of public healthChris Day, Marcia Stanhope
Gut|October 17, 2009
Childhood NAFLD: a ticking time-bomb?Valerio Nobili, Chris Day
Clinical Medicine (London, England)|November 5, 2009
Britain's alcohol market: how minimum alcohol prices could stop moderate drinkers subsidising those drinking at hazardous and harmful levelsChris Record, Chris Day
Digestive Diseases (Basel, Switzerland)|July 19, 2014
Treatment of non-alcoholic fatty liver diseaseJessica Dyson, Chris Day
Journal of Hepatology|June 4, 2015
Sugar sweetened beverages and fatty liver disease: Rising concern and call to actionManal F Abdelmalek, Chris Day
BMJ (Clinical Research Ed.)|October 13, 2016
Authors' reply to TavabieChris Day, Jessica Glen, Lefteris Floros, et al.
Current Pharmaceutical Design|February 12, 2013
From NAFLD to NASH and HCC: pathogenetic mechanisms and therapeutic insightsSamuele De Minicis, Chris Day, Gianluca Svegliati-Baroni
BMJ (Clinical Research Ed.)|September 9, 2016
Non-alcoholic fatty liver disease (NAFLD): summary of NICE guidanceJessica Glen, Lefteris Floros, Chris Day, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Annals of the Royal College of Surgeons of England|April 1, 2010
Comment on: Clarity of languageChris Day
Clinical Liver Disease|April 18, 2019
Natural history and factors influencing the course of alcohol-related liver diseaseStuart Kendrick, Chris Day
Imprint|March 5, 2004
Nurses strengthen the fabric of public healthChris Day, Marcia Stanhope
Gut|October 17, 2009
Childhood NAFLD: a ticking time-bomb?Valerio Nobili, Chris Day
Clinical Medicine (London, England)|November 5, 2009
Britain's alcohol market: how minimum alcohol prices could stop moderate drinkers subsidising those drinking at hazardous and harmful levelsChris Record, Chris Day
Digestive Diseases (Basel, Switzerland)|July 19, 2014
Treatment of non-alcoholic fatty liver diseaseJessica Dyson, Chris Day
Journal of Hepatology|June 4, 2015
Sugar sweetened beverages and fatty liver disease: Rising concern and call to actionManal F Abdelmalek, Chris Day
BMJ (Clinical Research Ed.)|October 13, 2016
Authors' reply to TavabieChris Day, Jessica Glen, Lefteris Floros, et al.
Current Pharmaceutical Design|February 12, 2013
From NAFLD to NASH and HCC: pathogenetic mechanisms and therapeutic insightsSamuele De Minicis, Chris Day, Gianluca Svegliati-Baroni
BMJ (Clinical Research Ed.)|September 9, 2016
Non-alcoholic fatty liver disease (NAFLD): summary of NICE guidanceJessica Glen, Lefteris Floros, Chris Day, et al.
Pageof 3